The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
Abstract
Context Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis that is common and is associated with an increased risk of death and ischemic events, yet may be underdiagnosed in primary care practice. Objective To assess the feasibility of detecting PAD in primary care clinics, patient and physician awareness of PAD, and intensity of risk factor treatment and use of antiplatelet therapies in primary care clinics. Design and setting The PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, a multicenter, cross-sectional study conducted at 27 sites in 25 cities and 350 primary care practices throughout the United States in June-October 1999. Patients A total of 6979 patients aged 70 years or older or aged 50 through 69 years with history of cigarette smoking or diabetes were evaluated by history and by measurement of the ankle-brachial index (ABI). PAD was considered present if the ABI was 0.90 or less, if it was documented in the medical record, or if there was a history of limb revascularization. Cardiovascular disease (CVD) was defined as a history of atherosclerotic coronary, cerebral, or abdominal aortic aneurysmal disease. Main outcome measures Frequency of detection of PAD; physician and patient awareness of PAD diagnosis; treatment intensity in PAD patients compared with treatment of other forms of CVD and with patients without clinical evidence of atherosclerosis. Results PAD was detected in 1865 patients (29%); 82…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, 30% of people aged 50-69 years with a history of cigarette smoking or diabetes, or aged $70 years regardless of risk factors, had PAD (233).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [233]
In the citing paper
“Notably, classical symptoms of claudication are uncommon, and almost half of people with newly diagnosed PAD were asymptomatic (233).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [233]
In the citing paper
“Notably, classical symptoms of claudication are uncommon, and almost half of people with newly diagnosed PAD were asymptomatic (223).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [223]
In the citing paper
“In the PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, 30% of people aged 50–69 years with a history of cigarette smoking or diabetes, or aged ≥70 years regardless of risk factors, had PAD (223).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [223]
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Cited by
Sorted by citations
Items 601–700 of 1,042
Ethnicity and peripheral arterial disease.
Collins, T. C., Petersen, N., Suarez-Almazor, M., & Ashton, C. (2005) · Mayo Clinic proceedings · doi:10.1016/s0025-6196(11)62957-1 · Cited by 13
Grant, C. C., Cuddeback, J. K., Alabi, O., Hicks, C. W., Sadik, K., & Ciemins, E. L. (2023) · Population Health Management · doi:10.1089/pop.2023.0095 · Cited by 13
Identifying Patients With Peripheral Artery Disease Using the Electronic Health Record
Sonderman, M., Aday, A., Farber-Eger, E., Mai, Q., Freiberg, M., Liebovitz, D. M., Greenland, P., McDermott, M., Beckman, J., & Wells, Q. (2023) · JACC: Advances · doi:10.1016/j.jacadv.2023.100566 · Cited by 12
“19 24 The high accuracy of this study certainly demonstrates the power of using machine learning to predict PAD status using a strategy of very high-risk patients (76% of patients in this study had coronary artery disease), but we believe the power of the EHR is to extend these methods to all…”
BackgroundExercise and the hallmarks of peripheral arterial disease
Peñín‐Grandes, S., Martín-Hernández, J., Valenzuela, P. L., López‐Ortiz, S., Pinto-Fraga, J., Solá, L. D. R., Emanuele, E., Lista, S., Lucía, A., & Santos‐Lozano, A. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.04.025 · Cited by 18
Kim, B., Seo, J., Kim, G., Jin, M., Lee, H., Byun, Y., & Kim, B. (2022) · Angiology · doi:10.1177/00033197221075853 · Cited by 12
“Lower extremity peripheral artery disease (PAD) is associated with an increased risk of cardiovascular disease as well as leg amputation.(1,2) Although the success rate of endovascular therapy (EVT) has increased with improvements in various devices and techniques, PAD remains an important factor causing reduced quali…”
BackgroundGouda, P., Ramasundarahettige, C. F., Anand, S. S., Muhlhoffer, E., Berkowitz, S. D., Fox, K. A. A., Eikelboom, J. W., & Welsh, R. C. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.07.003 · Cited by 12
Current and emerging drug treatment strategies for peripheral arterial disease
Essa, H., Torella, F., & Lip, G. Y. H. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1774556 · Cited by 12
“They demonstrated that at 18 months post diagnosis the use of cardioprotective medication in the PAD alone group vs the CAD alone group was substantially lower (any antiplatelet, 53% versus 66%; statins, 40% versus 52%; angiotensin-converting enzyme inhibitors, 20% versus 29”
BackgroundInfluentialBalancing Weight Loss and Sarcopenia in Elderly Patients With Peripheral Artery Disease
Kokkinidis, D. G., Armstrong, E. J., & Giri, J. (2019) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.119.013200 · Cited by 12
“Although only one third of affected patients have typical claudication symptoms at the time of diagnosis, up to 20% undergo an amputation within 10 years.(1,3-5) Individuals with PAD have higher risk for functional decline and impaired health-related quality of life (HRQOL) secondary to their ambulatory limitations.”
BackgroundGoldberg, E. J., Schmidt, C. A., Green, T. D., Karnekar, R., Yamaguchi, D. J., Spangenberg, E. E., & McClung, J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00804 · Cited by 12
Hackam, D., & Vyas, M. (2018) · American Journal of Medicine · doi:10.1016/j.amjmed.2018.07.006 · Cited by 12
Vasheghani-Farahani, A., Hosseini, K., Ashraf, H., Abolhasani, M., Karbalai, S., Ghajar, A., & Afarideh, M. (2017) · Diabetes & metabolic syndrome · doi:10.1016/j.dsx.2016.09.007 · Cited by 12
Nonatherosclerotic PAD: Approach to Exertional Pain in the Lower Extremities
Mintz, A. J., & Weinberg, I. (2015) · Current Cardiology Reports · doi:10.1007/s11886-015-0622-8 · Cited by 12
A practical approach to interpreting lower extremity noninvasive physiologic studies.
McCann, T. E., Scoutt, L., & Gunabushanam, G. (2014) · The Radiologic clinics of North America · doi:10.1016/j.rcl.2014.07.006 · Cited by 12
Medical Management of the Patient with Intermittent Claudication
Vodnala, D., Rajagopalan, S., & Brook, R. D. (2011) · Cardiology Clinics · doi:10.1016/j.ccl.2011.04.003 · Cited by 11
Enfermedad arterial periférica oculta en población diabética seguida en atención primaria
Romero, J. M., Gómez, F. P., Cerezuela, I. M., Osorio, A. B., Vera, S. R., Santos, P. G., & Felices, P. V. (2010) · doi:10.1016/j.arteri.2010.04.001 · Cited by 12
Assessment of public knowledge about the scope of practice of vascular surgons
Farber, A. M., Long, B. M., Lauterbach, S. R., Bohannon, T., & Siegal, C. L. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.08.091 · Cited by 11
Modified Ankle–brachial Index Detects More Patients at Risk in a Finnish Primary Health Care
Oksala, N., Viljamaa, J., Saimanen, E. I. T., & Venermo, M. A. (2009) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.11.007 · Cited by 14
McDermott, M., Mazor, K., Reed, G., Pagoto, S., Graff, R., Merriam, P., Kibbe, M., Greenland, P., Ockene, J., Olendzki, B. C., et al. (2010) · Vascular Medicine · doi:10.1177/1358863x09353653 · Cited by 12
Artériopathie et pied diabétique
Got, I. (2008) · doi:10.1016/s0248-8663(08)73953-5 · Cited by 12
Improving risk assessment with cardiac testing in peripheral arterial disease.
Feringa, H., Elhendy, A., Karagiannis, S., Noordzij, P., Dunkelgrun, M., Schouten, O., Vidakovic, R., van Domburg, R., Bax, J. J., & Poldermans, D. (2007) · American Journal of Medicine · doi:10.1016/j.amjmed.2006.06.041 · Cited by 12
Tratamento dietético da hiper-homocisteinemia na doença arterial periférica
Venâncio, L. D. S., Burini, R. C., & Yoshida, W. B. (2010) · doi:10.1590/s1677-54492010000100006 · Cited by 12
Medical Treatment of Peripheral Artery Disease
Gornik, H. L., & Creager, M. A. (2013) · Vascular Medicine: A Companion to Braunwald's Heart Disease · doi:10.1016/b978-1-4377-2930-6.00019-7 · Cited by 12
Smolderen, K. G., Ameli, O., Chaisson, C. E., Heath, K., & Mena-Hurtado, C. (2022) · AJPM Focus · doi:10.1016/j.focus.2022.100016 · Cited by 11
Nohara, S., Mok, Y.-J., Hof, J. V. V., Salameh, M. J., Joshu, C., Platz, E., Florido, R., & Matsushita, K. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2024.132577 · Cited by 11
Preventive Therapies in Peripheral Arterial Disease
Shah, A. J., Pavlatos, N., & Kalra, D. K. (2023) · Biomedicines · doi:10.3390/biomedicines11123157 · Cited by 12
The Indian Consensus Statement for the Management of Lower Extremity Peripheral Artery Disease
Khanna, N. N., Krishna, V. N., Manjunath, C., Tyagi, S., Jindal, R., Chadha, M. D., Natesh, B. H., Warawdekar, G., WANGNOO, S. K., Chopra, H. K., et al. (2023) · Journal of Indian College of Cardiology · doi:10.4103/1561-8811.383634 · Cited by 14
Chou, T.-H., Rimmerman, E. T., Patel, S. A., Wynveen, M. K., Eisert, S. N., Musini, K., Janse, S., Bobbey, A., Sarac, T. P., Atway, S. A., et al. (2023) · EJNMMI Research · doi:10.1186/s13550-023-00951-0 · Cited by 11
“Introduction Lower extremity PAD is a highly prevalent atherosclerotic disease that affects more than 230 million individuals worldwide [1] and is associated with significant morbidity [2], mortality [3], and economic burden [4–6].”
BackgroundCurrent Management of Peripheral Artery Disease: Focus on Pharmacotherapy
Golledge, J., Fernando, M. E., & Armstrong, D. G. (2022) · Drugs · doi:10.1007/s40265-022-01755-7 · Cited by 15
“Importantly, over half of the primary care physicians looking after the people with PAD were unaware of their diagnosis highlighting the need for greater PAD awareness [13].”
BackgroundGuidi, L., Lareyre, F., Chaudhuri, A., Le, D., Adam, C., Carrier, M., Hassen‐Khodja, R., Jean‐Baptiste, E., & Raffort, J. (2022) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2022.02.013 · Cited by 10
Meng, L., Graves, N., Du, R. C., Lee, J. Y., Chue, K. M., Hoo, N. N. F. B. T. C. A., Nazeha, N., Ng, Y. Z., Harding, K. G., & Ho, P. (2021) · International Wound Journal · doi:10.1111/iwj.13724 · Cited by 12
“Moreover, cardiovascular disease is more prevalent in NIU patients with PAD as both share similar atherosclerosis risk factor profiles(14); even after adjustment for known atherosclerosis-related risk factors, patients with PAD were still prospectively associated with higher risk of all-cause mortality compared with t…”
ResultDinesh, R., Vinod, K., & Ramkumar, G. (2021) · Medical Journal Armed Forces India · doi:10.1016/j.mjafi.2020.11.002 · Cited by 11
Puppala, M., Ezeana, C. F., Alvarado, M. V. Y., Goode, K., Danforth, R. L., Wong, S. S. Y., Vassallo, M. L., & Wong, S. T. C. (2020) · Medicine · doi:10.1097/md.0000000000023669 · Cited by 11
“7 Meanwhile, for patients with vascular diseases, it is recommended to provide more synchronized care and education about their condition to treat associated conditions such as hypertension and hyperlipidemia.([12]) Our institution schedules post-discharge follow up to better serve patients with chronic conditions whi…”
BackgroundPeter, L., Kracík, J., Černý, M., Noury, N., & Polzer, S. (2020) · Processes · doi:10.3390/pr8040442 · Cited by 13
“It has been shown that hypertension is a strong and independent risk factor of coronary heart disease [3], heart failure [4], peripheral arterial disease [5] or stroke disease [3,6,7].”
BackgroundEna, J., Pérez-Martín, S., Argente, C. R., & Lozano, T. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2019.11.003 · Cited by 12
Garg, P., Bůžková, P., Meyghani, Z., Budoff, M., Lima, J., Criqui, M., Cushman, M., & Allison, M. (2019) · European Heart Journal-Cardiovascular Imaging · doi:10.1093/ehjci/jez284 · Cited by 11
“19 Peripheral artery disease – Clinical PAD and Low ABI During follow-up, clinical PAD was identified by self-report of a hospitalized PAD diagnosis by the participant at (1) MESA clinic visits, (2) follow-up phone call, or (3) participant notification.”
BackgroundMethodInfluentialPetersohn, S., Ramaekers, B., Olie, R., ten Cate-Hoek, A. J., Daemen, J., ten Cate, H., & Joore, M. (2019) · Quality of Life Research · doi:10.1007/s11136-019-02166-0 · Cited by 11
The perfusion index is a useful screening tool for peripheral artery disease
Okada, H., Tanaka, M., Yasuda, T., Kamitani, T., Norikae, H., Fujita, T., Nishi, T., Oyamada, H., Yamane, T., & Fukui, M. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1276-4 · Cited by 11
The use of ankle brachial pressure indices in a cohort of black African diabetic patients
Weledji, E. P., Alemnju, N. T., & Nouediou, C. (2018) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2018.09.009 · Cited by 11
Hahn, H., Jeong, Y. S., Hong, Y. S., Won, J., Lim, S., Kim, J., Park, M., Park, D., & Lee, I. (2017) · Journal of Plastic, Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2017.01.010 · Cited by 11
Photoacoustic tomography: applications for atherosclerosis imaging
Sangha, G. S., & Goergen, C. (2016) · Journal of Optics · doi:10.1088/2040-8978/18/8/084005 · Cited by 11
Heikkilä, A., Venermo, M., Kautiainen, H., Aarnio, P., & Korhonen, P. (2016) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2015.11.004 · Cited by 11
Huang, X., Irmak, S., Lu, Y.-F., Pipinos, I., Casale, G., & Subbiah, J. (2015) · Biomedical Optics Express · doi:10.1364/boe.6.002766 · Cited by 11
Takeda, K., Duan, L., Takeda, H., & Fong, G. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.032 · Cited by 13
Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting.
Winfrey, C. A., Wortman, S. B., Frede, S., Kunze, N., Conrad, W., & Heaton, P. (2011) · Journal of the American Pharmacists Association · doi:10.1331/japha.2011.09160 · Cited by 11
Dekel, B. G. S., Melotti, R., Gargiulo, M., Freyrie, A., Stella, A., & Nino, G. D. (2010) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2010.02.016 · Cited by 11
Peripheral Arterial Disease and Clinical Risks in Taiwanese Hemodialysis Patients
Liu, J., Chang, C.-C., Wang, S.-M., Chou, C.-Y., Yang, Y.-F., Liu, Y.-L., Lin, H.-H., & Huang, C.-C. (2010) · Angiology · doi:10.1177/0003319709333867 · Cited by 11
Prevalência da doença arterial obstrutiva periférica em doentes com insuficiência renal crônica
Aragão, J., Reis, F. P., Borges, R., Aragão, M. E. C. D. S., Nunes, M. A. P., & Feitosa, V. L. C. (2009) · Jornal Vascular Brasileiro · doi:10.1590/s1677-54492009000400004 · Cited by 11
Panico, M. D. B., Spichler, E. S., Neves, M. F., Pinto, L. W., & Spichler, D. (2009) · Jornal Vascular Brasileiro · doi:10.1590/s1677-54492009005000009 · Cited by 11
Antithrombotic Therapy in Peripheral Arterial Disease
Lipsitz, E. C., & Kim, S. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2007.12.004 · Cited by 9
“Another report evaluated a patient group with risk factors for PVD and found that 29% of patients had PVD by ABI criteria, although only 11% presented with symptoms [28].”
BackgroundPatient awareness of risk factors for peripheral vascular disease.
Muthu, C., Chu, J. J., Heron, C. L., Roake, J., & Lewis, D. R. (2007) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2006.06.007 · Cited by 11
The vascular surgeon's role in risk factor modification: results of a survey.
Leon, L., Labropoulos, N., Lebda, P., & Kalman, P. (2005) · Perspectives in Vascular Surgery · doi:10.1177/153100350501700220 · Cited by 11
Approach to the patient with acute limb ischemia: diagnosis and therapeutic modalities.
Henke, P. (2002) · Cardiology Clinics · doi:10.1016/s0733-8651(02)00062-0 · Cited by 11
“Peripheral atherosclerotic (PAD) is common, estimated to be present in 29% of individuals over 65 years of age [1].”
BackgroundPeripheral Artery Disease: Atherosclerosis, Decreased Nitric Oxide, and Vascular Arterial Stiffening
Hayden, M. R. (2025) · Journal of Vascular Diseases · doi:10.3390/jvd4020021 · Cited by 11
“Indeed, the diagnosis of PAD should be considered a ‘red flag’ in that it serves as a biomarker for the increased risk, morbidity, and mortality of cardiovascular and cerebrovascular disease that should merit earlier detection and a more aggressive and sustained treatment plan [147].”
Bierowski, M. J., Galanis, T., Majeed, A., & Mofid, A. (2023) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.05.007 · Cited by 16
The Impact of Online Learning System on Students Affected with Stroke Disease
Wassan, S., Chen, X., Shen, T., Gulati, K., Ibraheem, K., & Latif, R. M. A. (2022) · Behavioural Neurology · doi:10.1155/2022/4847066 · Cited by 18
“Student10 has mixed behavior like in [34].”
RetractedYing, L.-W., Shen, Y., Zhang, Y., Wang, Y.-K., Liu, Y., Yin, J., Wang, Y.-F., Yin, J.-R., Zhu, W., Bao, Y., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.696156 · Cited by 10
“The mean age was 60 (53–66) years, and the mean diabetes duration was 11 (6-17) years.”
BackgroundNguyen, C., Marzolini, S., OH, P. I., & Thomas, S. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.04.013 · Cited by 11
Lee, C.-Y., Wu, T., & Lin, S.-J. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00860-8 · Cited by 10
Kokkinidis, D. G., Giannopoulos, S., Haider, M., Jordan, T., Sarkar, A., Singh, G. D., Secemsky, E., Giri, J., Beckman, J., & Armstrong, E. J. (2020) · Vascular Medicine · doi:10.1177/1358863x20916526 · Cited by 10
Vogel, T. R., Braet, D. J., Kruse, R., Bath, J., Wang, J.-Y., Gosch, K., & Smolderen, K. (2020) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2020.03.042 · Cited by 10
Garg, P., Bůžková, P., Wassell, C. L., Allison, M., Criqui, M., Larson, N., & Bielinski, S. (2020) · Angiology · doi:10.1177/0003319720912935 · Cited by 10
“During follow-up, clinical PAD was identified by self-report of a PAD diagnosis by the participant at (1) MESA clinic visits, (2) follow-up phone call, or (3) participant notification.”
BackgroundMethodManiatopoulos, G., Haining, S., Allen, J., & Wilkes, S. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4477-3 · Cited by 10
Eslami, M., Dakour-Aridi, H., Avgerinos, E., Makaroun, M., & Malas, M. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003521 · Cited by 10
“com considered as an earlier stage of PAD compared with chronic limb ischemia (CLI).(20,21) Our study indicates that utilization of LEB for claudication significantly increased in states that expanded Medicaid in 2014 compared with those that did not.”
ResultPeripheral Arterial Disease: Supervised Exercise Therapy Through Cardiac Rehabilitation.
Thomas, S. G., Marzolini, S., Lin, E., Nguyen, C. H., & Oh, P. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.07.009 · Cited by 10
Wojtasik-Bakalarz, J., Ruzsa, Z., Rakowski, T., Nyerges, A., Bartuś, K., Stanek, A., Dudek, D., Surdacki, A., Kleczyński, P., & Bartuś, S. (2019) · Journal of Diabetes Research · doi:10.1155/2019/6036359 · Cited by 14
“Cooccurrence of PAD and DM reaches more than 30% [17].”
BackgroundNew Curveball for Hypertension Guidelines?
Fudim, M., & Jones, W. S. (2018) · Circulation · doi:10.1161/circulationaha.118.036409 · Cited by 17
Statins in PAD: What are we waiting for?
Aday, A., & Everett, B. (2018) · Circulation · doi:10.1161/circulationaha.117.033092 · Cited by 10
Noyes, A. M., Abbott, J. D., Gosch, K., Smolderen, K., Spertus, J., Hyder, O., Soukas, P., Shishehbor, M. H., & Aronow, H. (2018) · Vascular Medicine · doi:10.1177/1358863x17747047 · Cited by 10
Caldieraro-Bentley, A. J., & Andrews, J. (2013) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2013.01.002 · Cited by 10
Jessup, D., & Lombardi, W. (2011) · Journal of interventional cardiology · doi:10.1111/j.1540-8183.2010.00626.x · Cited by 10
Keeling, A., Naughton, P., Khalidi, K., Ayyoub, A., Kelly, C., Leahy, A., Bouchier-Hayes, D., Athanasiou, T., & Lee, M. J. (2009) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2009.05.035 · Cited by 10
Medical Treatment of Peripheral Arterial Disease
Hiatt, W. (2008) · doi:10.1002/9780470692356.ch14 · Cited by 10
Lower extremity arterial and venous ulcers.
Sieggreen, M. (2005) · The Nursing Clinics of North America · doi:10.1016/j.cnur.2004.09.016 · Cited by 10
“The disease is not recognized by primary care providers [43].”
BackgroundArterial insufficiency and ulceration: diagnosis and treatment options.
Sieggreen, M., & Kline, R. A. (2004) · Advances in Skin & Wound Care · doi:10.1097/00129334-200406000-00013 · Cited by 10
Ogawa, T., Sugidachi, A., Tanaka, N., Fujimoto, K., & Asai, F. (2004) · Vascular pharmacology · doi:10.1016/j.vph.2004.03.001 · Cited by 10
Who should treat patients with peripheral arterial disease - the vascular specialist.
Sillesen, H. (2002) · European Journal of Vascular and Endovascular Surgery · doi:10.1053/ejvs.2002.1671 · Cited by 10
Overview of Peripheral Arterial Disease of the Lower Extremity
AbuRahma, A., & Campbell, J. (2021) · Noninvasive Vascular Diagnosis · doi:10.1007/978-1-4471-4005-4_20 · Cited by 10
Treatment of peripheral arterial disease.
Regensteiner, J., & Hiatt, W. (2002) · Clinical Cornerstone · doi:10.1016/s1098-3597(02)90014-1 · Cited by 10
Smolderen, K. G., Heath, K., Scherr, T., Bauzon, S. R., Howell, A. N., & Mena-Hurtado, C. (2022) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2022.01.134 · Cited by 9
Shoji, S., Shah, N. P., Shrader, P., Thomas, L. E., Arnold, J. D., Dhalwani, N. N., Thomas, N. A., Kalich, B. A., Priest, E. L., Syed, M., et al. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100921 · Cited by 9
From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic Status
Boccatonda, A., D’Ardes, D., Moronti, V., Santilli, J., Cipollone, A., Lessiani, G., Gregorio, N. D., Serra, C., Piscaglia, F., Ferri, C., et al. (2024) · Medicina · doi:10.3390/medicina60111781 · Cited by 8
Pharmacotherapy and revascularization strategies of peripheral artery disease
Moras, E., Khan, M. I., Song, D. D., Syed, M., Prabhakaran, S. Y., Gandhi, K., Lavie, C. J., Alam, M., Sharma, R. M., & Krittanawong, C. (2024) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2024.102430 · Cited by 10
Ramirez, J. L., Wang, K. M., Sung, E., Hernandez, S., Le, M., Avra, T. D., Talutis, S. D., Iannuzzi, J. C., & Ulloa, J. G. (2023) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2023.10.029 · Cited by 9
Bridgwood, B., & Sayers, R. (2023) · Family Practice · doi:10.1093/fampra/cmad048 · Cited by 9
Is Triglyceride-Glucose Index a Valuable Parameter in Peripheral Artery Disease?
Çalışkan, S., & Böyük, F. (2023) · Cureus · doi:10.7759/cureus.35532 · Cited by 8
“However, in approximately half of the patients, the disease can manifest asymptomatically or present with atypical complaints [24].”
BackgroundImpact of anticoagulation/antiplatelet therapy on femoropopliteal bypass graft outcomes
Kim, Y., DeCarlo, C. S., Patel, S. S., McElroy, I. E., Majumdar, M., Jessula, S., Lee, S., Mohapatra, A., & Dua, A. (2022) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2022.06.005 · Cited by 9
Vascular Surgery Curriculum for Medical Students: A National Targeted Needs Assessment.
Dorsey, C., McKenzie, N., Milner, R., Lee, J. T., & Schindler, N. (2021) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2021.08.040 · Cited by 9
Chruewkamlow, N., Pruekprasert, K., Phutthakunphithak, P., Acharayothin, O., Prapassaro, T., Hongku, K., Hahtapornsawan, S., Puangpunngam, N., Chinsakchai, K., Wongwanit, C., et al. (2021) · Stem cell research & therapeutics · doi:10.1186/s13287-021-02592-3 · Cited by 9
Chen, Y.-C., Sheu, J., Chiang, J. Y., Shao, P.-L., Wu, S.-C., Sung, P., Li, Y.-C., Chen, Y.-L., Huang, T.-H., Chen, K.-H., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217887 · Cited by 9
“Patients with PAOD may develop critical limb ischemia (CLI) at the late stage of the disease process [2,3].”
BackgroundLee, J. H., Kim, Y., Lee, Y.-C., Bang, W., & Seo, J. (2020) · Diabetes & vascular disease research · doi:10.1177/1479164120945910 · Cited by 9
Garg, P., Jorgensen, N., McClelland, R., Allison, M., Stein, J., Yvan-Chavret, L., Tall, A., & Shea, S. (2020) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2020.02.007 · Cited by 9
Lee, F., Luo, C., Wallace, C. G., Chen, K.-H., Sheu, J., Yin, T.-C., Chai, H.-T., & Yip, H. (2019) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2019.109296 · Cited by 9
Rodriguez–Leyva, D., Portelles, A. R., Weighell, W., Guzman, R., Maddaford, T. G., & Pierce, G. N. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0280 · Cited by 18
Stalling, P., Engelbertz, C. M., Lüders, F., Meyborg, M., Gebauer, K., Waltenberger, J. L., Reinecke, H., & Freisinger, E. (2019) · Clinical Cardiology · doi:10.1002/clc.23186 · Cited by 9
“Not only that recognition of early stage PAD remains a matter of particular significance but also is consequent treatment of risk factors and timely prevention.(34,35) Finally, further research is imperative on how to effectively address the adverse impact of DM and CAD as major predictors of limb loss and mortality i…”
BackgroundDialogue between primary and secondary health care providers in a Brazilian hypertensive population
Vanelli, C. P., Costa, M. B., Colugnati, F. A. B., Sanders‐Pinheiro, H., de Paula, E. A., Leite, C. C. A., Casagrande, M. Z., de Sousa, K. V., & de Paula, R. B. (2018) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.64.09.799 · Cited by 7
ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model
Ferreira, C., Hernandez, R., Yang, Y.-N., Valdovinos, H., Engle, J., & Cai, W. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00424 · Cited by 9
Singh, J. A., & Cleveland, J. (2018) · Rheumatology · doi:10.1093/rheumatology/kex232 · Cited by 9
Contemporary and Optimal Medical Management of Peripheral Arterial Disease
Tattersall, M. C., Johnson, H. M., & Mason, P. J. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.04.009 · Cited by 7
Liu, X., Terry, T., Pan, S., Yang, Z., Willerson, J., Dixon, R., & Liu, Q. (2013) · Journal of Visualized Experiments · doi:10.3791/50364 · Cited by 9
The association between peripheral artery and lumbar spine disease: a single-center study.
Ain, D. L., Slovut, D., Kamath, R., & Jaff, M. (2012) · American Journal of Medicine · doi:10.1016/j.amjmed.2011.09.008 · Cited by 9
Metadata
- Authors
- Hirsch, A. T.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Hirsch, Alan T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-09-19
- Volume
- 286
- Issue
- 11
- Pages
- 1317
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2140136269
- Cited by
- 2,835
- References
- 0
- Citations by year
- 2026: 59 · 2025: 77 · 2024: 89 · 2023: 102 · 2022: 113 · 2021: 127 · 2020: 100 · 2019: 105 · 2018: 147 · 2017: 105 · 2016: 135 · 2015: 122 · 2014: 160 · 2013: 145 · 2012: 166
- FWCI
- 62.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k07hl003435-05)
- National Heart, Lung, and Blood Institute (1-K07-HL03435-01)
- Topics
- Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
- Keywords
- peripheral arterial disease, ankle-brachial index, underdiagnosis, patient awareness, physician awareness, cardiovascular disease, atherosclerosis, antiplatelet therapy, smoking cessation, diabetes mellitus, intermittent claudication, primary care, older adults, limb revascularization, cardiovascular risk stratification, diabetes self-management education
- MeSH terms
- Aged, Arteriosclerosis, Cardiovascular Diseases, Cross-Sectional Studies, Family Practice, Female, Humans, Intermittent Claudication, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Ultrasonography, Doppler
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review